The organic EBITDA growth expectation includes the full-year impact of synergies from the integration
of Agio Cigars, an increase in operating costs relating to the ramp-up of our sustainability initiatives,
increased cyber security initiatives as well as the normalization of certain costs that have been lower
during the COVID-19 period like sales and marketing spending. The development in organic EBITDA
growth also reflects the absence of other income from the refund of certain duty and excise taxes of
DKK 31 million which was realized in 2021 and the loss of net sales and profits following the Russian
invasion of Ukraine.
Organic EBITDA growth is expected to be negative in the second quarter of the year with the perfor-
mance in the comparable quarter in 2021 being above normal. Organic EBITDA growth is expected to
turn positive in the third quarter and fourth quarter as the comparison base normalizes and as the
performance from the business initiatives starts to be reflected in financial numbers.
Based on the projected earnings growth, we expect the Group´s free cash flow before acquisitions to
be in the range of DKK 1.1-1.4 billion. The free cash flow before acquisitions is expected to be impacted
by investments in the retail expansion in the US and the ERP-project One Process, a negative impact
from working capital of up to DKK 200 million (previously about DKK 100 million) as well as a negative
impact from special items of about DKK 200 million.
The adjusted EPS is expected to increase by more than 5% (from DKK 14.8 in 2021) including a
positive impact from the share repurchases of about DKK 1.0 per share and a positive impact from
currency developments.
The financial performance for Scandinavian Tobacco Group for the full year 2022 rests on several key
assumptions:
• The positive impact of the COVID-19 pandemic on demand for handmade cigars in North
America is expected to have peaked, and the demand is expected to resume its long-term
structural volume decline rate of about -2%
• In Europe, we are assuming the product categories to return to their long-term structural de-
velopment
• No major supply-chain disruptions are anticipated during the year
Annual General Meeting
At the Annual General Meeting held on 31 March 2022, the shareholders approved a dividend of DKK
7.50 per share resulting in a total dividend pay-out of about DKK 700 million. It was also approved to
reduce the share capital by 4,500,000 own shares with a nominal value of DKK 1. Following the re-
duction, which was implemented on 4 May 2022, the number of shares is 93,000,000.
The shareholders re-elected Henrik Brandt, Anders Obel, Dianne Neal Blixt, Marlene Forsell, Claus
Gregersen and Henrik Amsinck as members of the Board of Directors. Nigel Northridge and Luc Mis-
sorten decided to retire from the Board of Directors at the Annual General Meeting.
The Board of Directors has appointed Henrik Brandt as Chairman of the Board of Directors and Mar-
lene Forsell as chairman of the Audit Committee.
Events after the reporting period
There are no other events than those mentioned in the above that have occurred after 31 March 2022
and that are expected to have material impact on the financial position of the Group.
Forward-looking statements
This report contains forward-looking statements. Such statements are subject to risk and uncertainties
as various factors, many of which are beyond Scandinavian Tobacco Group’s control, may cause
actual developments and results to differ materially from the expectations set out in this report.